ABQid

Kane Robotics designs and manufactures collaborative robotics systems for aerospace and defense manufacturing, offering lightweight, low-cost cobot-based automation for grinding, sanding and finishing, drilling, epoxy dispensing and machine tending. Its solutions are standardized and off-the-shelf, complemented by system integration services to support high-mix, low-volume production and to free skilled workers from repetitive tasks. The company focuses on improving productivity and efficiency, with applications across aerospace manufacturing and related industries. The company was established in 2019 and is based in Albuquerque, New Mexico.

X-Bow Launch Systems Inc., located in Albuquerque, New Mexico, specializes in the production of advanced solid rocket motors and hypersonic technologies for both commercial and government applications. The company provides a comprehensive service that encompasses the design, testing, and launching of solid propellant systems. Utilizing additive manufacturing technology, X-Bow develops customizable and cost-effective rocket motors, positioning itself as an innovative player in the aerospace industry.

Fetch Delivery Inc. is a mobile application-based company that provides local delivery services, facilitating the connection between customers and businesses in their communities. Established in 2013 and headquartered in Santa Fe, New Mexico, Fetch Delivery allows users to order a variety of items, including groceries, pharmacy products, laundry services, and food from local restaurants and shops. The platform aims to enhance convenience for customers while helping local businesses increase their sales by reaching a broader customer base. Through its user-friendly service, Fetch Delivery addresses the growing demand for on-demand delivery solutions in urban environments.

Peptineo, LLC is a biotechnology company based in Albuquerque, New Mexico, specializing in the development, marketing, and licensing of innovative drug discovery, delivery, and stabilization technologies. Founded in 2011, the company focuses on a range of products, including aerosolized antibiotics designed to treat infections associated with cystic fibrosis and ventilator-associated pneumonia, as well as topical antibiotics for conditions such as MRSA. Peptineo is also advancing nucleic acid vaccines targeting norovirus and providing aerosolized antimicrobial agents for wound care. The company engages in research on therapeutic peptides, reformulation of existing drugs, and the development of hybrid compounds that combine recombinant biological proteins with traditional chemical entities. Additionally, Peptineo offers consulting services in biotechnology and pharmaceutical research, alongside outsourced research and development for new biological compounds. Through its systems-based approach, Peptineo aims to enhance and accelerate the drug discovery process using advanced technologies such as tunable nano-carriers and engineered peptides.